GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » ROA %

Cognetivity Neurosciences (Cognetivity Neurosciences) ROA % : -1,541.89% (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Cognetivity Neurosciences's annualized Net Income for the quarter that ended in Oct. 2023 was $-5.94 Mil. Cognetivity Neurosciences's average Total Assets over the quarter that ended in Oct. 2023 was $0.39 Mil. Therefore, Cognetivity Neurosciences's annualized ROA % for the quarter that ended in Oct. 2023 was -1,541.89%.

The historical rank and industry rank for Cognetivity Neurosciences's ROA % or its related term are showing as below:

CGNSF' s ROA % Range Over the Past 10 Years
Min: -684.95   Med: -307.57   Max: -78.28
Current: -422.48

During the past 7 years, Cognetivity Neurosciences's highest ROA % was -78.28%. The lowest was -684.95%. And the median was -307.57%.

CGNSF's ROA % is ranked worse than
97.79% of 678 companies
in the Healthcare Providers & Services industry
Industry Median: 1.36 vs CGNSF: -422.48

Cognetivity Neurosciences ROA % Historical Data

The historical data trend for Cognetivity Neurosciences's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences ROA % Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
ROA %
Get a 7-Day Free Trial -177.23 -364.47 -150.90 -687.60 -299.73

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -142.34 -263.68 -405.45 -841.95 -1,541.89

Competitive Comparison of Cognetivity Neurosciences's ROA %

For the Health Information Services subindustry, Cognetivity Neurosciences's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's ROA % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's ROA % distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's ROA % falls into.



Cognetivity Neurosciences ROA % Calculation

Cognetivity Neurosciences's annualized ROA % for the fiscal year that ended in Jan. 2023 is calculated as:

ROA %=Net Income (A: Jan. 2023 )/( (Total Assets (A: Jan. 2022 )+Total Assets (A: Jan. 2023 ))/ count )
=-5.539/( (1.588+2.108)/ 2 )
=-5.539/1.848
=-299.73 %

Cognetivity Neurosciences's annualized ROA % for the quarter that ended in Oct. 2023 is calculated as:

ROA %=Net Income (Q: Oct. 2023 )/( (Total Assets (Q: Jul. 2023 )+Total Assets (Q: Oct. 2023 ))/ count )
=-5.944/( (0.416+0.355)/ 2 )
=-5.944/0.3855
=-1,541.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Oct. 2023) net income data. ROA % is displayed in the 30-year financial page.


Cognetivity Neurosciences  (OTCPK:CGNSF) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Oct. 2023 )
=Net Income/Total Assets
=-5.944/0.3855
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-5.944 / 0.084)*(0.084 / 0.3855)
=Net Margin %*Asset Turnover
=-7076.19 %*0.2179
=-1,541.89 %

Note: The Net Income data used here is four times the quarterly (Oct. 2023) net income data. The Revenue data used here is four times the quarterly (Oct. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Cognetivity Neurosciences ROA % Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019